Sarah Cannon Blood Cancer Network Unveils Innovative Blood And Marrow Transplantation Technology With Velos, Inc.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon, the cancer institute of Hospital Corporation of America (NYSE: HCA), and StafaCT, Inc., an affiliate of clinical research and specialty medical software provider, Velos Inc., announced their partnership in developing new technology for comprehensive electronic blood and marrow transplantation (BMT). Together, the partners created Stafa, a software focused on elevating patient care by managing the transplantation process and supporting the ability to monitor FACT compliance and process improvement.